However, GLN has also demonstrated contradictory effects, such as reducing BW gain and liver weight and mitigating obesity-induced insulin resistance and impaired insulin signaling in the liver [38]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.